Duke Quinton

Background

Duke joined Dehns in 2017 after graduating from the University of Oxford with an Undergraduate Master’s degree in Molecular and Cellular Biochemistry. During his final academic year, Duke worked in the Kleanthous group, investigating the translocation mechanisms of protein antibiotics across the outer membrane of Escherichia coli.

Duke qualified as a European Patent Attorney in 2021 and qualified as a Chartered (UK) Patent Attorney in 2024. 

Types of clients and client work

Duke works with a variety of clients, including small/medium-sized enterprises, universities and multinational companies. Duke handles prosecution of patent applications in Europe, and has experience of prosecution in a number of other jurisdictions including Canada, China, Japan, the UK and the US. Duke also assists with client work outside of prosecution, including freedom to operate analysis and patent application drafting.

Expertise

Duke handles patent applications relating to a variety of technologies within the life sciences, including antibodies, anti-cancer therapies, genome editing techniques, medical diagnostic techniques, fish farming and pharmaceuticals.

Qualifications and Memberships

• Chartered (UK) Patent Attorney, 2024
• Authorised Representative before the Unified Patent Court (UPC), 2023
• European Patent Attorney, 2021
• PGCert (Intellectual Property Law), Queen Mary University of London, 2018
• Fellow of the Chartered Institute of Patent Attorneys (CIPA)
  
• Member of the European Patent Institute (epi)

Higher Education

MBiochem (Molecular and Cellular Biochemistry), University of Oxford, 2017

Other

Duke will be attending the CIPA Life Sciences Conference 2024, from the 21st – 22nd November. Please contact Duke if you would like to arrange a meeting at the event.